Dual Influenza and Pneumococcal Vaccination Was Associated with Lower Short-term Risks of All-cause and Acute Respiratory Hospitalizations Among the Elderly in Shenzhen, China: a Retrospective Cohort Study

Overview

Journal Emerg Microbes Infect

Specialty Infectious Diseases

Date 2020 Nov 20

PMID 33215981

Citations 2

Authors

Yawen Jiang

Zhaojia Ye

Daqin Chen

Yuelong Shu

Affiliations

Soon will be listed here.

Abstract

The present study evaluated the real-world effectiveness of influenza and pneumococcal dual-vaccination among Chinese elderly, the evidence on which was absent. Outpatient and inpatient claims databases from Jan 1, 2015 to Apr 1, 2017 of persons at least 60 years old in Shenzhen, China were merged with electronic records of influenza vaccines and 23-valent pneumococcal polysaccharide vaccines (PPSV23) from Oct 1, 2016 - May 31, 2017. Individuals who were vaccinated with influenza between Nov 1 and Dec 31, 2016 and received PPSV23 30 days within the date of influenza vaccination were defined as the vaccinated group. A control group consisted of individuals that received neither of the vaccines was constructed by matching on year of birth, sex, and district. The two outcomes were all-cause and acute respiratory hospitalizations. Difference-in-difference (DiD) logistic regressions that were proceeded with an entropy balancing (EB) process were used to analyse the effectiveness of dual-vaccination. A total of 48,116 eligible individuals were identified in the vaccinated group, which were matched by 93,692 individuals in the control group. The EB-DiD analyses estimated that dual-vaccination was associated with lower short-term risks of all-cause (odds ratio: 0.59, CI: 0.55-0.63) and acute respiratory (odds ratio: 0.49, CI: 0.41-0.59) hospitalizations.

Citing Articles

Attitudes Toward General Vaccination Mediate the Association Between Influenza Vaccination History and Pneumococcal Vaccination Intention Among Older Adults in China.

Huang S, Ruan C, Jiang Y, Song Y, Zhang Y, Qin Z Vaccines (Basel). 2025; 13(1).

PMID: 39852799 PMC: 11769291. DOI: 10.3390/vaccines13010020.

Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study.

Pi Z, Aoyagi K, Arima K, Wu X, Ye Z, Jiang Y Vaccines (Basel). 2023; 11(1).

PMID: 36680005 PMC: 9863432. DOI: 10.3390/vaccines11010161.

Manifesto on the Value of Adult Immunization: "We Know, We Intend, We Advocate".

Antonelli-Incalzi R, Blasi F, Conversano M, Gabutti G, Giuffrida S, Maggi S Vaccines (Basel). 2021; 9(11).

PMID: 34835163 PMC: 8625332. DOI: 10.3390/vaccines9111232.

References

Mues K, Liede A, Liu J, Wetmore J, Zaha R, Bradbury B . Use of the Medicare database in epidemiologic and health services research: a valuable source of real-world evidence on the older and disabled populations in the US. Clin Epidemiol. 2017; 9:267-277. PMC: 5433516. DOI: 10.2147/CLEP.S105613. View

Gostin L, Salmon D . The Dual Epidemics of COVID-19 and Influenza: Vaccine Acceptance, Coverage, and Mandates. JAMA. 2020; 324(4):335-336. DOI: 10.1001/jama.2020.10802. View

Chen Q, Wang L, Xie M, Li X . Recommendations for influenza and vaccination in elderly people in China. Aging Med (Milton). 2020; 3(1):1-11. PMC: 7099755. DOI: 10.1002/agm2.12102. View

Yin M, Huang L, Zhang Y, Yu N, Xu X, Liang Y . Effectiveness and safety of dual influenza and pneumococcal vaccination versus separate administration or no vaccination in older adults: a meta-analysis. Expert Rev Vaccines. 2018; 17(7):653-663. DOI: 10.1080/14760584.2018.1495077. View

Yang J, Atkins K, Feng L, Pang M, Zheng Y, Liu X . Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016; 34(47):5724-5735. DOI: 10.1016/j.vaccine.2016.10.013. View

Izurieta H, Thadani N, Shay D, Lu Y, Maurer A, Foppa I . Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis. 2015; 15(3):293-300. PMC: 4834448. DOI: 10.1016/S1473-3099(14)71087-4. View

Hu S, Shi Q, Chen C, Caldwell R, Wang B, Du L . Estimated public health impact of nationwide vaccination of infants with 7-valent pneumococcal conjugate vaccine (PCV7) in China. Int J Infect Dis. 2014; 26:116-22. DOI: 10.1016/j.ijid.2014.04.012. View

Ozawa S, Portnoy A, Getaneh H, Clark S, Knoll M, Bishai D . Modeling The Economic Burden Of Adult Vaccine-Preventable Diseases In The United States. Health Aff (Millwood). 2016; 35(11):2124-2132. DOI: 10.1377/hlthaff.2016.0462. View

Zhou H, Taber C, Arcona S, Li Y . Difference-in-Differences Method in Comparative Effectiveness Research: Utility with Unbalanced Groups. Appl Health Econ Health Policy. 2016; 14(4):419-429. PMC: 4937082. DOI: 10.1007/s40258-016-0249-y. View

10.

Zhang Y, Tang X, Du C, Wang B, Bi Z, Dong B . Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis. Hum Vaccin Immunother. 2016; 12(12):3056-3064. PMC: 5215556. DOI: 10.1080/21645515.2016.1221552. View

11.

Dimick J, Ryan A . Methods for evaluating changes in health care policy: the difference-in-differences approach. JAMA. 2014; 312(22):2401-2. DOI: 10.1001/jama.2014.16153. View

12.

Li X, Leng S . Influenza immunization among Chinese seniors: Urgent calling for improving vaccination coverage, education, and research. Aging Med (Milton). 2020; 3(1):12-15. PMC: 7099750. DOI: 10.1002/agm2.12103. View

13.

Nohynek H, Baum U, Syrjanen R, Ikonen N, Sundman J, Jokinen J . Effectiveness of the live attenuated and the inactivated influenza vaccine in two-year-olds - a nationwide cohort study Finland, influenza season 2015/16. Euro Surveill. 2016; 21(38). PMC: 5073199. DOI: 10.2807/1560-7917.ES.2016.21.38.30346. View

14.

Li L, Liu Y, Wu P, Peng Z, Wang X, Chen T . Influenza-associated excess respiratory mortality in China, 2010-15: a population-based study. Lancet Public Health. 2019; 4(9):e473-e481. PMC: 8736690. DOI: 10.1016/S2468-2667(19)30163-X. View

15.

Wang Y, Cheng M, Wang S, Wu F, Yan Q, Yang Q . Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017. BMC Public Health. 2020; 20(1):359. PMC: 7081528. DOI: 10.1186/s12889-020-8388-3. View

16.

Shi W, Ke C, Fang S, Li J, Song H, Li X . Co-circulation and persistence of multiple A/H3N2 influenza variants in China. Emerg Microbes Infect. 2019; 8(1):1157-1167. PMC: 6713139. DOI: 10.1080/22221751.2019.1648183. View

17.

Chang Y, Chou Y, Liu J, Yeh T, Huang N . Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan--a representative population-based comparative study. J Infect. 2012; 65(3):231-8. DOI: 10.1016/j.jinf.2012.04.014. View

18.

Hung I, Tantawichien T, Tsai Y, Patil S, Zotomayor R . Regional epidemiology of invasive pneumococcal disease in Asian adults: epidemiology, disease burden, serotype distribution, and antimicrobial resistance patterns and prevention. Int J Infect Dis. 2013; 17(6):e364-73. DOI: 10.1016/j.ijid.2013.01.004. View

19.

Song J, Lee J, Wie S, Kim H, Lee J, Seo Y . Prospective cohort study on the effectiveness of influenza and pneumococcal vaccines in preventing pneumonia development and hospitalization. Clin Vaccine Immunol. 2014; 22(2):229-34. PMC: 4308868. DOI: 10.1128/CVI.00673-14. View

20.

Zhang Y, Muscatello D, Wang Q, Yang P, Wu J, MacIntyre C . Overview of influenza vaccination policy in Beijing, China: Current status and future prospects. J Public Health Policy. 2017; 38(3):366-379. DOI: 10.1057/s41271-017-0079-7. View